** Shares of medical device maker Zimmer Biomet Holdings ZBH.N rise 1.5% to $103.87 premarket
** ZBH posts Q1 adj. profit of $1.81 per share, beating analysts' estimate of $1.77 per share, according to data compiled by LSEG
** Company reports Q1 revenue of $1.91 billion vs estimates of $1.90 billion
** Company cuts its annual adj profit forecast to a range of $7.9 and $8.1 per share, compared with previously projected adj profit forecast of $8.15 to $8.35 per share
** However, ZBH expects 2025 revenue growth to be 5.7% to 8.2% including co's acquisition of orthopedic surgical devices maker Paragon 28 7GQ.F, currency and current tariff impact
** As of last close, ZBH has fallen 3.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.